Cognitive Computing in Pharmacovigilance: Revamping Drug Safety Using an Advanced Computing System

Jan 15, 2018

Today’s pharmacovigilance department faces some of the most vexing issues facing life sciences companies. Among the major functions of a pharmacovigilance department, case management is considered to be the most resource-intensive and costly process. This white paper shares how cognitive computing has the potential to revamp the practice of pharmacovigilance, from a tedious, resource-intensive process to a dynamic and efficient practice. Download this white paper for an overview of cognitive computing, the issues facing PV that make it a strong candidate for using advanced machine-learning technology, the various technologies involved, and how each life science company can prepare to be ready for its beneficial transformation.

About ArisGlobal

ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

Additional Information

Connect with ArisGlobal on LinkedIn:
Follow @Aris_Global on Twitter:


Erika Thomas
+305-726-6601 |